−1.30USD
−104.86 MUSD
58.38 MUSD
71.66 M
About Immatics N.V.
Sector
Industry
CEO
Harpreet Singh-Jasuja
Website
Headquarters
Tuebingen
Employees (FY)
343
Founded
2020
ISIN
NL0015285958
FIGI
BBG00VTL9Y81
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
